Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis

por Gualtierotti, Roberta, Ruscica, Massimiliano
Publicado 2023

Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid

por Ferri, Nicola, Corsini, Alberto, Ruscica, Massimiliano
Publicado 2023

Role of lipoprotein(a) in plaque progression

por Ruscica, Massimiliano, Rizzuto, Alessandra S, Corsini, Alberto
Publicado 2022

The Role of High-Density Lipoprotein Cholesterol in 2022

por Sirtori, Cesare R., Corsini, Alberto, Ruscica, Massimiliano
Publicado 2022

Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review

por Gianazza, Erica, Macchi, Chiara, Banfi, Cristina, Ruscica, Massimiliano
Publicado 2023

Resveratrol and cognitive decline: a clinician perspective

por Cicero, Arrigo F.G., Ruscica, Massimiliano, Banach, Maciej
Publicado 2019

Protocol to evaluate the impact of murine MCT1-deficient CD8(+) T cells on adipogenesis

por Macchi, Chiara, Moregola, Annalisa, Norata, Giuseppe Danilo, Ruscica, Massimiliano
Publicado 2023

Fixed Combination for the Treatment of Dyslipidaemia

por Ferri, Nicola, Ruscica, Massimiliano, Santos, Raul D., Corsini, Alberto
Publicado 2023

Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studies

por Ferri, Nicola, Greco, Maria Francesca, Corsini, Alberto, Ruscica, Massimiliano
Publicado 2020

Lipoprotein(a) and PCSK9 inhibition: clinical evidence

por Ruscica, Massimiliano, Greco, Maria Francesca, Ferri, Nicola, Corsini, Alberto
Publicado 2020

New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran

por Ruscica, Massimiliano, Sirtori, Cesare Riccardo, Ferri, Nicola, Corsini, Alberto
Publicado 2021

Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease

por Adorni, Maria Pia, Ruscica, Massimiliano, Ferri, Nicola, Bernini, Franco, Zimetti, Francesca
Publicado 2019

Impact of PPAR-Alpha Polymorphisms—The Case of Metabolic Disorders and Atherosclerosis

por Ruscica, Massimiliano, Busnelli, Marco, Runfola, Enrico, Corsini, Alberto, Sirtori, Cesare R.
Publicado 2019

Clinical approach to the inflammatory etiology of cardiovascular diseases

por Ruscica, Massimiliano, Corsini, Alberto, Ferri, Nicola, Banach, Maciej, Sirtori, Cesare R.
Publicado 2020

Unravelling the health effects of fasting: a long road from obesity treatment to healthy life span increase and improved cognition

por Wilhelmi de Toledo, Françoise, Grundler, Franziska, Sirtori, Cesare R., Ruscica, Massimiliano
Publicado 2020

Bempedoic Acid: for Whom and When

por Ruscica, Massimiliano, Sirtori, Cesare R., Carugo, Stefano, Banach, Maciej, Corsini, Alberto
Publicado 2022

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?

por Carugo, Stefano, Sirtori, Cesare R., Corsini, Alberto, Tokgozoglu, Lale, Ruscica, Massimiliano
Publicado 2022

Naturally Occurring PCSK9 Inhibitors

por Adorni, Maria Pia, Zimetti, Francesca, Lupo, Maria Giovanna, Ruscica, Massimiliano, Ferri, Nicola
Publicado 2020

Lipid Lowering Drugs: Present Status and Future Developments

por Ruscica, Massimiliano, Ferri, Nicola, Santos, Raul D., Sirtori, Cesare R., Corsini, Alberto
Publicado 2021

PPAR Agonists and Metabolic Syndrome: An Established Role?

por Botta, Margherita, Audano, Matteo, Sahebkar, Amirhossein, Sirtori, Cesare R., Mitro, Nico, Ruscica, Massimiliano
Publicado 2018